Cleo Diagnostics Ltd (ASX:COV)
Australia · Delayed Price · Currency is AUD 0.3600
-0.0050 (-1.37%)
At close: Jul 17, 2026
Cleo Diagnostics Market Cap
Cleo Diagnostics has a market cap or net worth of 49.27 million as of July 17, 2026. Its market cap has increased by 3.63% in one year.
Market Cap
49.27M
Enterprise Value
39.84M
Revenue
2.56M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.36
ChartMarket Cap Chart
Since August 15, 2023, Cleo Diagnostics's market cap has increased from 25.70M to 49.27M, an increase of 91.71%. That is a compound annual growth rate of 24.94%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 49.27M | -40.50% |
| Dec 31, 2025 | 82.80M | 81.51% |
| Dec 31, 2024 | 45.62M | 102.86% |
| Dec 29, 2023 | 22.49M | -12.50% |
| Aug 15, 2023 | 25.70M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SomnoMed | 100.78M |
| Lumos Diagnostics Holdings | 84.05M |
| Epiminder | 74.64M |
| OncoSil Medical | 47.43M |
| Compumedics | 44.95M |
| HeraMED | 43.98M |
| CleanSpace Holdings | 31.56M |
| Nova Eye Medical | 31.33M |